124 related articles for article (PubMed ID: 38253255)
21. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
[TBL] [Abstract][Full Text] [Related]
23. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
24. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
[TBL] [Abstract][Full Text] [Related]
25. Molecular alterations in gastric cancer with special reference to the early-onset subtype.
Skierucha M; Milne AN; Offerhaus GJ; Polkowski WP; Maciejewski R; Sitarz R
World J Gastroenterol; 2016 Feb; 22(8):2460-74. PubMed ID: 26937134
[TBL] [Abstract][Full Text] [Related]
26. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
27. CDH1 mutations in gastric cancers are not associated with family history.
Choi S; Jang J; Heo YJ; Kang SY; Kim ST; Lee J; Kang WK; Kim JW; Kim KM
Pathol Res Pract; 2020 May; 216(5):152941. PubMed ID: 32241597
[TBL] [Abstract][Full Text] [Related]
28. Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.
Cheng Y; Bu D; Zhang Q; Sun R; Lyle S; Zhao G; Dong L; Li H; Zhao Y; Yu J; Hao X
J Adv Res; 2023 Sep; 51():121-134. PubMed ID: 36351537
[TBL] [Abstract][Full Text] [Related]
29. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
30. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558
[TBL] [Abstract][Full Text] [Related]
31. Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.
Li X; Wu WK; Xing R; Wong SH; Liu Y; Fang X; Zhang Y; Wang M; Wang J; Li L; Zhou Y; Tang S; Peng S; Qiu K; Chen L; Chen K; Yang H; Zhang W; Chan MT; Lu Y; Sung JJ; Yu J
Cancer Res; 2016 Apr; 76(7):1724-32. PubMed ID: 26857262
[TBL] [Abstract][Full Text] [Related]
32. Novel CDH1 germline mutations identified in Chinese gastric cancer patients.
Chen QH; Deng W; Li XW; Liu XF; Wang JM; Wang LF; Xiao N; He Q; Wang YP; Fan YM
World J Gastroenterol; 2013 Feb; 19(6):909-16. PubMed ID: 23431106
[TBL] [Abstract][Full Text] [Related]
33. Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients.
Zhu C; Yang Q; Xu J; Zhao W; Zhang Z; Xu D; Zhang Y; Zhao E; Zhao G
J Transl Med; 2019 Apr; 17(1):109. PubMed ID: 30944005
[TBL] [Abstract][Full Text] [Related]
34. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Richards FM; McKee SA; Rajpar MH; Cole TR; Evans DG; Jankowski JA; McKeown C; Sanders DS; Maher ER
Hum Mol Genet; 1999 Apr; 8(4):607-10. PubMed ID: 10072428
[TBL] [Abstract][Full Text] [Related]
35. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
[TBL] [Abstract][Full Text] [Related]
36. Characterizing genomic differences of human cancer stratified by the TP53 mutation status.
Wang M; Yang C; Zhang X; Li X
Mol Genet Genomics; 2018 Jun; 293(3):737-746. PubMed ID: 29330617
[TBL] [Abstract][Full Text] [Related]
37. Targeted next-generation sequencing for cancer-associated gene mutation and copy number detection in 206 patients with non-small-cell lung cancer.
Zheng S; Wang X; Fu Y; Li B; Xu J; Wang H; Huang Z; Xu H; Qiu Y; Shi Y; Li K
Bioengineered; 2021 Dec; 12(1):791-802. PubMed ID: 33629637
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations in collagens are associated with a distinct tumor environment and overall survival in gastric cancer.
Brodsky AS; Khurana J; Guo KS; Wu EY; Yang D; Siddique AS; Wong IY; Gamsiz Uzun ED; Resnick MB
BMC Cancer; 2022 Feb; 22(1):139. PubMed ID: 35120467
[TBL] [Abstract][Full Text] [Related]
39. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
40. KLF5 Is Activated by Gene Amplification in Gastric Cancer and Is Essential for Gastric Cell Proliferation.
Chen W; Zhang J; Fu H; Hou X; Su Q; He Y; Yang D
Cells; 2021 Apr; 10(5):. PubMed ID: 33923166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
